To redeem tainted pharma industry, India puts in place new standards
Drugmakers must inform the licensing authority about product recalls, defects, deterioration or faulty production. There was no such provision earlier.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in
You may also like
ANI’s copyright strikes aren’t the problem, its access is
The news agency is being questioned for enforcing its copyright. But the government needs to be asked why ANI is given such exclusive access in the first place.
SC order reversing Delhi HC’s Wikipedia ruling is a small win for media freedom
The Supreme Court set aside a Delhi High Court ruling that asked Wikipedia to remove an article about court proceedings in a case filed by ANI.
US crackdown on tech investments in China could be India’s missed opportunity
India will need to bring about massive changes if it wants to take advantage of the US’s solidifying stance against tech investments in China.